The US Federal Trade Commission approved the purchase of the Irish pharmaceutical company Shire by Japanese Takeda Pharmaceutical, the largest pharmaceutical company in Asia, for 46 billion pounds sterling. The message of Takeda said that the deal would lead the Japanese company into the top 10 pharmaceutical companies in the world in terms of revenue. Takeda expects that the deal, which is the largest in the history of deals of the Japanese companies with the purchase of foreign assets, will be closed in the first half of 2019. The deal has yet to be agreed in a number of other countries, including the EU, Japan and China.
Japanese exports, core machinery orders decline amid coronavirus risks14.02.2020
Japanese policymakers prepare for Q4 GDP decline and virus risks13.02.2020
Facebook defers launch of dating service in Europe as Irish officials hold search operation in offices29.01.2020
Apple’s iPhone back on track as company secures gains against coronavirus